AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04367623 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Brain computer interface based therapy
Description: Participants who decide to take part will be assigned to a treatment or a control group. Both groups will have the same assessments and the same number of therapy sessions. Therapy group will have a training that consists of Brain Computer Interface controlled Functional Electrical Stimulation followed by a physical practice of the dominant upper limb, while the control group will have a physical practice only. One experimental session will last about 60 min for both groups (including setup and therapy) and participants in each group will receive 20 sessions, about 3 times per week. The expected time needed for completion of 20 sessions is 7 weeks
Study NCT01423747 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: VP16
Description: patients with MSD receive as conditioning VP16 60mg/kg/d on day -3
Study NCT01423747 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: TBI
Description: patients with a MSD receive TBI (12Gy in 6 fractions) as conditioning
Study NCT01423747 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: VP16, ATG
Description: patients with a HLA matched unrelated Donor (9/10 oder 10/10) receive VP16 60mg/kg/d on day -3 and ATG fresenius 20mg/kg/d on day -3,-2,-1
Study NCT01423747 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: TBI
Description: patients with a HLA matched unrelated Donor (9/10 oder 10/10) receive TBI (12Gy in 6 fractions)
Study NCT01423747 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Fludarabine, OKT3, Treosulfan, Thiotepa
Description: patients with a MMD (haploidentical or cord blood) receive Fludarabine 30mg/m²/d on day -9 to -5, ATG 20mg/kd/d on day -3 to day -1, Treosulfan 14g/m²/d on day -7 to -5 and Thiotepa 2x5mg/kg/d on day -4
Study NCT01423747 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: VP16, ATG
Description: patients with MMD-transplantation (8/10)receive VP16 60mg/kg/d on day -4, ATG from day -3 to day-1 20mg/kg/d
Study NCT01423747 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: TBI
Description: patients with a MMD-transplantation (8/10) receive 12 Gy in 6 fractions
Study NCT00567398 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dianeal
Description: Dianeal 1.5% Dextrose (1.38% Glucose), 2.5% Dextrose (2.27% Glucose), 4.25% Dextrose (3.86% Glucose)
Study NCT00567398 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Physioneal
Description: Physioneal 40 or Physioneal 35
Study NCT00567398 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Extraneal
Description: Extraneal - 7.5% Icodextrin
Study NCT00567398 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nutrineal
Description: Nutrineal - 1.1% Amino Acids
Study NCT01118000 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: limb ischemia preconditioning
Description: limb ischemic preconditioning consists of three 5-min cycles of left upper limb ischemia induced by a blood pressure cuff placed on the left upper arm and inflated to 200 mmHg,with an intervention 5-min of reperfusion during which the cuff was deflated.
Study NCT00587496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: valacyclovir hydrochloride
Description: 500 mg capsule, one per day for 30 days
Study NCT00587496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo
Description: lactose placebo capsule, six per day for 30 days
Study NCT00587496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: valacyclovir plus aspirin
Description: 500 mg valacyclovir capsule, one per day for 30 days 325 mg acetyl salicylic acid (aspirin) capsule, three per day for 30 days placebo capsule, two per day for 30 days
Study NCT01402102 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Aged garlic powder
Description: Aged garlic powder(6.0g/day)
Study NCT01402102 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo powder
Description: Placebo powder(6.0g/day)
Study NCT03264729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isometric exercise
Description: The isometric exercise is performed standing with the forefoot on a step. The participant is instructed to stand still with the ankle joint in neutral and hold this position. Supporting oneself for balance by placing the hands on a wall or a rail is allowed. The participant performs 5 sets of 45-second isometric holds. The load used is the heaviest possible load that the participant is able to withstand for 1 minute. As with the isotonic exercise, if the participant's body weight is inadequate the participant is fitted with a backpack with books and/or weights.
Study NCT03264729 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Isotonic exercise
Description: The isotonic exercise is performed standing with the forefoot on a step. The toes are maximally dorsi-flexed by placing a towel underneath them. The participant is instructed to perform a heel-raise to a maximal plantar flexion in the ankle joint, and afterwards to lower the heel to maximal dorsi flexion. Supporting oneself for balance by placing the hands on a wall or a rail is allowed. The participant performs 4 sets of 8 repetitions with a load of 8RM. The contraction time is 3s concentric, 2s isometric and 3s eccentric and will be guided by a metronome.~If the participant's body weight is inadequate to reach sufficient loading during the exercises the participant is fitted with a backpack with books and/or weights.
Study NCT03264729 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Walking
Description: The walking will be performed barefoot and the participant will be instructed in walking at a pace similar to the pace they would use when walking around in their home. The duration of the walking session will be four minutes to match the duration during the exercises.
Study NCT02214394 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-performance liquid chromatography Analysis
Description: Blood samples will be collected for HPLC analysis to compare with the breath samples.
Study NCT02214394 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SMART Device
Description: Breath collection for GC-MS analysis to compare with Blood collection.
Study NCT01452841 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Grapefruit
Description: 1.5 Rio Red Grapefruit consumed daily for 6 weeks
Study NCT01452841 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Participants followed a diet low in bioactive rich fruits and vegetables and avoided citrus for six weeks
Study NCT01344525 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic gastric sleeve
Description: Laparoscopic gastric sleeve
Study NCT01344525 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Gastric Banding
Description: Gastric Banding
Study NCT01344525 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multidisciplinary lifstyle intervention
Description: Multidisciplinary lifstyle intervention (OPTIFAST®52-program)
Study NCT01344525 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Roux-en-Y Bypass
Description: Roux-en-Y Bypass
Study NCT02216604 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multimodal Exercise Intervention
Description: During their inpatient hospitalization the participants perform 3-5x weekly guided training sessions about 15-30min. The intervention includes: game console-based training using Nintendo Wii® (endurance, strength endurance and balance), age-specific resistance training and sessions of body awareness. During the outpatient phases the participants perform a home-based exercise training 3-5x weekly using a training manual. In addition, the patients obtain a movement diary and a pedometer for documenting their activity level.
Study NCT05808569 — intervention group
Intervention type: BEHAVIORAL
Intervention: Test
Description: A specific self-test composed by 16 questions , will be administered to BC patients undergoing adjuvant RT.
Study NCT02223858 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Activities (PA) Program
Description: 6-week program of at-home activities (1 per week) that have been shown to increase positivity. Activities were delivered via activity booklets and oral instructions provided during weekly telephone calls from trained interventionists. Interventionist oriented participants to the booklets and reviewed the first activity at the end of an in-person baseline visit. Booklets contained all instructions patients needed to complete the full program. Interventionists also provided support via weekly calls in which they assessed completion of the previous week's activity, reviewed instructions for the next activity, and helped participants trouble-shoot anticipated barriers.
Study NCT02223858 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention Control (AC) Program
Description: 6-week program of at-home activities (1 per week) based on affectively neutral activities from control conditions in studies of positive activities interventions. Activities were delivered via activity booklets and oral instructions provided during weekly telephone calls from trained interventionists. Interventionist oriented participants to the booklets and reviewed the first activity at the end of an in-person baseline visit. Booklets contained all instructions patients needed to complete the full program. Interventionists also provided support via weekly calls in which they assessed completion of the previous week's activity, reviewed instructions for the next activity, and helped participants trouble-shoot anticipated barriers.
Study NCT02901704 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Renal Denervation System (AngioCare)
Description: After a renal angiography according to standard procedures, subjects remain blinded and are immediately treated with the renal denervation procedure after randomization.
Study NCT02901704 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham procedure
Description: After a renal angiography according to standard procedures, subjects remain blinded and remain on the catheterization lab table for at least 10 minutes prior to introducer sheath removal.
Study NCT04936087 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: The World Health Organization 8 steps for manual wheelchair service delivery
Description: All study participants were provided with a new wheelchair, a wheelchair cushion, and wheelchair services, delivered by trained wheelchair service providers, according to the WHO 8-step wheelchair service delivery process including assessment, fitting, and a 30-minute individual or group training on 7 wheelchair skills, device care, and pressure injury prevention techniques. Additionally, wheelchair maintenance reminders were sent through a text message service (SMS) to a sub-cohort of participants.~Wheelchair users were provided with one of three different, International Standards Organization (ISO) tested, wheelchair models according to the users' needs and availability: standard, active, and all-terrain models. All wheelchairs were provided with a basic contour cushion made of polyurethane foam. However, whenever a risk of pressure injury was identified for a study participant, wheelchair providers fabricated a pressure-relief cushion.
Study NCT03338127 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: renal function test
Description: 2 ml blood sample to be investigated for renal function test
Study NCT00194493 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ESRA-C
Description: Graphical summary of patient symptoms and quality of life
Study NCT02288455 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GTU Artificial Urinary Sphincter
Description: A totally implantable Artificial Urinary Sphincter (AUS) for the treatment of male Stress Urinary Incontinence (SUI)
Study NCT01254708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ambisome ®
Description: liposomal amphotericin B
Study NCT01254708 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Regular standard of care medication
Description: Drug for this group is at the physician's discretion. Patients in this group receive the standard of care medication currently implemented at the Institution. Example would be voriconazole
Study NCT01984528 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: four differente concentrations of Alternaria alternata allergen extract, positive control and negative control
Description: This concentrations will be tested in every patient in duplicate on the volar surface of the forearm.
Study NCT01094145 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Deep brain stimulation
Description: DBS in the Nucleus basalis Meynert
Study NCT01094145 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Deep brain stimulation
Description: DBS in the Nucleus basalis Meynert
Study NCT04422158 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nuun electrolyte tablet
Description: Each table contains 2 grams of carbohydrate and a combination of electrolytes. calcium (13mg, 1%DV), sodium (300mg, 13%DV), potassium (150mg, 3%DV), magnesium (25mg, 6%DV), and chloride (40mg, 2%DV).
Study NCT04422158 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: water
Description: water
Study NCT04422158 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: water
Description: water
Study NCT02465827 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: nerve block with ropivacaine
Description: Ultrasound guided nerve blocks of the saphenous and obturator nerve, posterior branch with ropivacaine 0.75% for both nerve branches
Study NCT02465827 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: nerve block with ropivacaine and with saline
Description: nerve blocks of the saphenous nerve with ropivacaine 0.75% and obturator nerve, posterior branch with saline
Study NCT02465827 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: nerve block with saline
Description: Ultrasound guided nerve blocks of the saphenous and obturator nerve, posterior branch with saline for both nerve branches
Study NCT01644357 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care
Description: Pharmacist intervention, focused on the optimization of drug therapy, identification and resolution of drug related problems, resulting in best asthma control and quality of life. Pharmacists document their initial and monthly follow up encounters using a specified form. An action plan for self management of these patients was prepared and discussed aiming at early identification and treatment of an exacerbation episode. Meetings will be held weekly with intervention team to discuss action plan and measure of outcomes of all problems identified.
Study NCT05155514 — intervention group
Intervention type: PROCEDURE
Intervention: Mobil-O-Graph PWA
Description: After resting in a quiet room preoperatively, blood pressure was measured on the right arm using an oscillometric method.
Study NCT00473382 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Description: Sterile solution for intravitreal injection.
Study NCT00473382 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sham injection
Study NCT01019083 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be given according to randomization list
Study NCT01019083 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control
Description: Control will be selected from the Arsenic non contaminated Area
Study NCT01019083 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zinc Sulphate
Description: Zinc Sulphate will be given according to randomization list
Study NCT01019083 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albendazole and Secnidazole
Description: Albendazole and Secnidazole will be given according to randomization list
Study NCT01019083 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Arsenic
Description: Participant will be selected from the Arsenic Contaminated Area
Study NCT03588884 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcifediol Oral Capsule
Description: Capsule, daily
Study NCT03588884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcifediol Oral Product
Description: Capsule, once a month
Study NCT03588884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cholecalciferol
Description: Capsule, once a month
Study NCT03588884 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cholecalciferol
Description: Capsule, once a month
Study NCT03588884 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paricalcitol Oral Capsule
Description: Capsule, daily
Study NCT01302249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%
Description: q.d.
Study NCT01302249 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Latanoprost 0.005%
Description: q.d.
Study NCT01302249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AR-12286 Ophthalmic Solution 0.5%
Study NCT01302249 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Timolol maleate ophthalmic solution 0.5%
Study NCT01356251 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires & online virtual support group
Description: Part 1 surveys mesothelioma patients' psychological and physical symptom burden and quality of life by administering a set of questionnaires that covers topics including coping, interpersonal support, mood, anxiety, and overall quality of life. All mesothelioma patients who complete the questionnaires in part 1 will be offered an opportunity to participate in a trial of a therapeutic Internet-based discussion group. The groups will consist of either approximately 3-5 surgical patients or approximately 3-5 non-surgical patients. The groups will run for approximately 60 minutes once a week for six consecutive weeks.
Study NCT01356251 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires & online virtual support group
Description: Part 1 surveys mesothelioma patients' psychological and physical symptom burden and quality of life by administering a set of questionnaires that covers topics including coping, interpersonal support, mood, anxiety, and overall quality of life. All mesothelioma patients who complete the questionnaires in part 1 will be offered an opportunity to participate in a trial of a therapeutic Internet-based discussion group. The groups will consist of either 3-5 surgical patients or 3-5 non-surgical patients. The groups will run for approximately 60 minutes once a week for six consecutive weeks.
Study NCT01347619 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Toolkit only with Web Access to Online Version
Description: NHs in this arm will receive a letter announcing the availability of an atypical antipsychotic toolkit within the facility and online at the Qualidigm website. The letter will be sent to the NH administrator, Director of Nursing, and Medical Director of each facility by Qualidigm. It will state that the toolkit is designed to provide NH staff, including prescribers, leadership, nursing staff, and patients' families with information about the use, risks and costs of atypical antipsychotics in the NH setting.
Study NCT01347619 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Toolkit, Periodic Audit/Feedback, Educational Messages
Description: Providing healthcare professionals with data about their performance (audit and feedback) may help improve their practice. It is more effective when clinicians previously agree to review their practice. We will use an adaptation of a Medicaid Utilization Report developed by AM Hamer. This report will show current atypical antipsychotic prescribing rates in the NH, with comparisons to state and national levels, and information regarding summary evidence for atypical antipsychotics from the AHRQ atypical antipsychotic CERSG. Reports will be sent to the NH administrator, Director of Nursing, and Medical Director of the facilities randomized to the moderate intensity arm on an every 4-month basis.
Study NCT01347619 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Items in Arm 2 plus Academic Detailing Program
Description: This arm will receive the same information, toolkit, letters, and audit and feedback reports distributed to homes in the moderate-intensity arm. In addition, two visits to the NH will be scheduled by a pharmacist educator specially trained in the pharmacology of atypical antipsychotics, and communication techniques. Staff will be provided with up-to-date, unbiased information about antipsychotic use in NHs based on the AHRQ CER Review product adaptations. The educator will deliver targeted messages relevant to each stakeholder regarding roles in decision-making around the use atypical antipsychotic therapy in the NH setting. Each NH will receive up to two visits over the course of the 12-month intervention period.
Study NCT00133068 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computer
Description: Computer intervention only
Study NCT00133068 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reduction in financial barrier
Description: Copay only
Study NCT00133068 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computer intervention & reduction of financial barrier
Description: computer intervention \& copay
Study NCT00133068 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Control
Description: No intervention
Study NCT00679796 — intervention group
Intervention type: PROCEDURE
Intervention: Varicella (chickenpox) lesion sampling
Study NCT01155518 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: testosterone
Description: intramuscular every 2 weeks
Study NCT01155518 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: clomiphene
Description: thrice a week